Compare Immunefi (IMU) vs Kava (KAVA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Immunefi vs Kava — how do they compare? Immunefi trades at Rp24.67 (market cap Rp27,03M, Rp39,91M 24h volume), while Kava trades at Rp826.42 (market cap Rp890,87M, Rp170,36M 24h volume). The key difference: Kava is far larger — about 33× Immunefi's market cap, and Immunefi's supply is capped (873,4M / 10B IMU (9%)) while Kava's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Immunefi for 5 Days and Kava for 55 Days on average.
| IMU | KAVA | |
|---|---|---|
Market Cap | Rp27,03M | Rp890,87M |
Volume (24h) | Rp39,91M | Rp170,36M |
Circulating Supply | 873,4M / 10B IMU (9%) | 1,1B KAVA |
Typical Hold Time | 5 Days | 55 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Immunefi (IMU) currently trades with a market cap of Rp27.03M and a circulating supply of 873.4 million tokens (9% of max supply). The asset shows limited market activity with a short average hold time of 5 days, indicating potential speculative trading patterns. Recent coverage appears to confuse the token with a corporate entity, requiring careful verification of crypto-specific metrics.
Outlook remains cautious due to low circulation rate and potential identity confusion. Key opportunity lies in proper crypto ecosystem positioning, while major risks include liquidity constraints and market misidentification. Investors should verify on-chain metrics and exchange listings before considering exposure.
Kava is trading at Rp816.03 with a market cap of Rp882.77 million, showing neutral technical signals overall. The asset is in a consolidation phase near the pivot point of Rp808, with immediate resistance at Rp824 and support at Rp800. Key indicators like RSI_12 at 69.14 suggest neutral momentum, while ADX_6 at 53.20 indicates a strong trend. No major protocol upgrades or ecosystem news have been reported recently, keeping fundamental developments quiet.
The outlook for Kava remains neutral with opportunities in its established support levels but risks from low liquidity and high volatility. Investors should monitor for breakout above Rp824 or breakdown below Rp800, alongside any upcoming network updates that could drive adoption. Major risks include regulatory uncertainty and thin trading volumes exacerbating price swings.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Immunefi
Immunefi is a security-focused ecosystem token designed to reward contributions to blockchain safety. It aligns protocols, researchers, and communities through bug bounties, staking, and governance incentives. The ecosystem also integrates AI to enhance threat detection and scale protection as the on-chain economy grows.
Read more on IMU →About Kava
KAVA is a cross-chain DeFi lending platform that allows users to borrow USDX stablecoins and deposit a variety of cryptocurrencies to begin earning a yield. Built on the Cosmos blockchain, Kava makes use of a collateralized debt position (CDP) system to ensure stablecoin loans are always sufficiently collateralized.
Read more on KAVA →
